XABEMELI Trademark

Trademark Overview


On Wednesday, January 28, 2015, a trademark application was filed for XABEMELI with the United States Patent and Trademark Office. The USPTO has given the XABEMELI trademark a serial number of 86517322. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 24, 2018. This trademark is owned by Eli Lilly and Company. The XABEMELI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
xabemeli

General Information


Serial Number86517322
Word MarkXABEMELI
Filing DateWednesday, January 28, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 24, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 7, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, September 24, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 24, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, February 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2018EXTENSION 5 GRANTED
Monday, January 29, 2018EXTENSION 5 FILED
Monday, January 29, 2018TEAS EXTENSION RECEIVED
Thursday, August 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2017EXTENSION 4 GRANTED
Friday, July 21, 2017EXTENSION 4 FILED
Thursday, August 3, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 21, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2017EXTENSION 3 GRANTED
Wednesday, January 25, 2017EXTENSION 3 FILED
Wednesday, January 25, 2017TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 23, 2016EXTENSION 2 GRANTED
Thursday, June 30, 2016EXTENSION 2 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Tuesday, December 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 28, 2015EXTENSION 1 GRANTED
Monday, November 23, 2015EXTENSION 1 FILED
Monday, December 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 23, 2015TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 23, 2015ASSIGNED TO EXAMINER
Saturday, February 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 2, 2015NEW APPLICATION ENTERED IN TRAM